Global Active Pharmaceutical Ingredients (API) Market Insights and Forecast to 2027
Table of Contents1 Study Coverage
1.1 Active Pharmaceutical Ingredients (API) Product Introduction
1.2 Market by Type
1.2.1 Global Active Pharmaceutical Ingredients (API) Market Size Growth Rate by Type
1.2.2 Synthetic APIs
1.2.3 Biotech APIs
1.3 Market by Application
1.3.1 Global Active Pharmaceutical Ingredients (API) Market Size Growth Rate by Application
1.3.2 CNS
1.3.3 Cardiovascular
1.3.4 Genitourinary/Hormonal Drugs
1.3.5 Respiratory
1.3.6 Rheumatology
1.3.7 Diabetes
1.3.8 Oncology
1.3.9 Others
1.4 Study Objectives
1.5 Years Considered
2 Global Active Pharmaceutical Ingredients (API) Production
2.1 Global Active Pharmaceutical Ingredients (API) Production Capacity (2016-2027)
2.2 Global Active Pharmaceutical Ingredients (API) Production by Region: 2016 VS 2021 VS 2027
2.3 Global Active Pharmaceutical Ingredients (API) Production by Region
2.3.1 Global Active Pharmaceutical Ingredients (API) Historic Production by Region (2016-2021)
2.3.2 Global Active Pharmaceutical Ingredients (API) Forecasted Production by Region (2022-2027)
2.4 North America
2.5 Europe
2.6 China
2.7 Japan
2.8 India
3 Global Active Pharmaceutical Ingredients (API) Sales in Volume & Value Estimates and Forecasts
3.1 Global Active Pharmaceutical Ingredients (API) Sales Estimates and Forecasts 2016-2027
3.2 Global Active Pharmaceutical Ingredients (API) Revenue Estimates and Forecasts 2016-2027
3.3 Global Active Pharmaceutical Ingredients (API) Revenue by Region: 2016 VS 2021 VS 2027
3.4 Global Top Active Pharmaceutical Ingredients (API) Regions by Sales
3.4.1 Global Top Active Pharmaceutical Ingredients (API) Regions by Sales (2016-2021)
3.4.2 Global Top Active Pharmaceutical Ingredients (API) Regions by Sales (2022-2027)
3.5 Global Top Active Pharmaceutical Ingredients (API) Regions by Revenue
3.5.1 Global Top Active Pharmaceutical Ingredients (API) Regions by Revenue (2016-2021)
3.5.2 Global Top Active Pharmaceutical Ingredients (API) Regions by Revenue (2022-2027)
3.6 North America
3.7 Europe
3.8 Asia-Pacific
3.9 Latin America
3.10 Middle East & Africa
4 Competition by Manufactures
4.1 Global Active Pharmaceutical Ingredients (API) Supply by Manufacturers
4.1.1 Global Top Active Pharmaceutical Ingredients (API) Manufacturers by Production Capacity (2020 VS 2021)
4.1.2 Global Top Active Pharmaceutical Ingredients (API) Manufacturers by Production (2016-2021)
4.2 Global Active Pharmaceutical Ingredients (API) Sales by Manufacturers
4.2.1 Global Top Active Pharmaceutical Ingredients (API) Manufacturers by Sales (2016-2021)
4.2.2 Global Top Active Pharmaceutical Ingredients (API) Manufacturers Market Share by Sales (2016-2021)
4.2.3 Global Top 10 and Top 5 Companies by Active Pharmaceutical Ingredients (API) Sales in 2020
4.3 Global Active Pharmaceutical Ingredients (API) Revenue by Manufacturers
4.3.1 Global Top Active Pharmaceutical Ingredients (API) Manufacturers by Revenue (2016-2021)
4.3.2 Global Top Active Pharmaceutical Ingredients (API) Manufacturers Market Share by Revenue (2016-2021)
4.3.3 Global Top 10 and Top 5 Companies by Active Pharmaceutical Ingredients (API) Revenue in 2020
4.4 Global Active Pharmaceutical Ingredients (API) Sales Price by Manufacturers
4.5 Analysis of Competitive Landscape
4.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
4.5.2 Global Active Pharmaceutical Ingredients (API) Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.5.3 Global Active Pharmaceutical Ingredients (API) Manufacturers Geographical Distribution
4.6 Mergers & Acquisitions, Expansion Plans
5 Market Size by Type
5.1 Global Active Pharmaceutical Ingredients (API) Sales by Type
5.1.1 Global Active Pharmaceutical Ingredients (API) Historical Sales by Type (2016-2021)
5.1.2 Global Active Pharmaceutical Ingredients (API) Forecasted Sales by Type (2022-2027)
5.1.3 Global Active Pharmaceutical Ingredients (API) Sales Market Share by Type (2016-2027)
5.2 Global Active Pharmaceutical Ingredients (API) Revenue by Type
5.2.1 Global Active Pharmaceutical Ingredients (API) Historical Revenue by Type (2016-2021)
5.2.2 Global Active Pharmaceutical Ingredients (API) Forecasted Revenue by Type (2022-2027)
5.2.3 Global Active Pharmaceutical Ingredients (API) Revenue Market Share by Type (2016-2027)
5.3 Global Active Pharmaceutical Ingredients (API) Price by Type
5.3.1 Global Active Pharmaceutical Ingredients (API) Price by Type (2016-2021)
5.3.2 Global Active Pharmaceutical Ingredients (API) Price Forecast by Type (2022-2027)
6 Market Size by Application
6.1 Global Active Pharmaceutical Ingredients (API) Sales by Application
6.1.1 Global Active Pharmaceutical Ingredients (API) Historical Sales by Application (2016-2021)
6.1.2 Global Active Pharmaceutical Ingredients (API) Forecasted Sales by Application (2022-2027)
6.1.3 Global Active Pharmaceutical Ingredients (API) Sales Market Share by Application (2016-2027)
6.2 Global Active Pharmaceutical Ingredients (API) Revenue by Application
6.2.1 Global Active Pharmaceutical Ingredients (API) Historical Revenue by Application (2016-2021)
6.2.2 Global Active Pharmaceutical Ingredients (API) Forecasted Revenue by Application (2022-2027)
6.2.3 Global Active Pharmaceutical Ingredients (API) Revenue Market Share by Application (2016-2027)
6.3 Global Active Pharmaceutical Ingredients (API) Price by Application
6.3.1 Global Active Pharmaceutical Ingredients (API) Price by Application (2016-2021)
6.3.2 Global Active Pharmaceutical Ingredients (API) Price Forecast by Application (2022-2027)
7 North America
7.1 North America Active Pharmaceutical Ingredients (API) Market Size by Type
7.1.1 North America Active Pharmaceutical Ingredients (API) Sales by Type (2016-2027)
7.1.2 North America Active Pharmaceutical Ingredients (API) Revenue by Type (2016-2027)
7.2 North America Active Pharmaceutical Ingredients (API) Market Size by Application
7.2.1 North America Active Pharmaceutical Ingredients (API) Sales by Application (2016-2027)
7.2.2 North America Active Pharmaceutical Ingredients (API) Revenue by Application (2016-2027)
7.3 North America Active Pharmaceutical Ingredients (API) Sales by Country
7.3.1 North America Active Pharmaceutical Ingredients (API) Sales by Country (2016-2027)
7.3.2 North America Active Pharmaceutical Ingredients (API) Revenue by Country (2016-2027)
7.3.3 U.S.
7.3.4 Canada
8 Europe
8.1 Europe Active Pharmaceutical Ingredients (API) Market Size by Type
8.1.1 Europe Active Pharmaceutical Ingredients (API) Sales by Type (2016-2027)
8.1.2 Europe Active Pharmaceutical Ingredients (API) Revenue by Type (2016-2027)
8.2 Europe Active Pharmaceutical Ingredients (API) Market Size by Application
8.2.1 Europe Active Pharmaceutical Ingredients (API) Sales by Application (2016-2027)
8.2.2 Europe Active Pharmaceutical Ingredients (API) Revenue by Application (2016-2027)
8.3 Europe Active Pharmaceutical Ingredients (API) Sales by Country
8.3.1 Europe Active Pharmaceutical Ingredients (API) Sales by Country (2016-2027)
8.3.2 Europe Active Pharmaceutical Ingredients (API) Revenue by Country (2016-2027)
8.3.3 Germany
8.3.4 France
8.3.5 U.K.
8.3.6 Italy
8.3.7 Russia
9 Asia Pacific
9.1 Asia Pacific Active Pharmaceutical Ingredients (API) Market Size by Type
9.1.1 Asia Pacific Active Pharmaceutical Ingredients (API) Sales by Type (2016-2027)
9.1.2 Asia Pacific Active Pharmaceutical Ingredients (API) Revenue by Type (2016-2027)
9.2 Asia Pacific Active Pharmaceutical Ingredients (API) Market Size by Application
9.2.1 Asia Pacific Active Pharmaceutical Ingredients (API) Sales by Application (2016-2027)
9.2.2 Asia Pacific Active Pharmaceutical Ingredients (API) Revenue by Application (2016-2027)
9.3 Asia Pacific Active Pharmaceutical Ingredients (API) Sales by Region
9.3.1 Asia Pacific Active Pharmaceutical Ingredients (API) Sales by Region (2016-2027)
9.3.2 Asia Pacific Active Pharmaceutical Ingredients (API) Revenue by Region (2016-2027)
9.3.3 China
9.3.4 Japan
9.3.5 South Korea
9.3.6 India
9.3.7 Australia
9.3.8 Taiwan
9.3.9 Indonesia
9.3.10 Thailand
9.3.11 Malaysia
9.3.12 Philippines
10 Latin America
10.1 Latin America Active Pharmaceutical Ingredients (API) Market Size by Type
10.1.1 Latin America Active Pharmaceutical Ingredients (API) Sales by Type (2016-2027)
10.1.2 Latin America Active Pharmaceutical Ingredients (API) Revenue by Type (2016-2027)
10.2 Latin America Active Pharmaceutical Ingredients (API) Market Size by Application
10.2.1 Latin America Active Pharmaceutical Ingredients (API) Sales by Application (2016-2027)
10.2.2 Latin America Active Pharmaceutical Ingredients (API) Revenue by Application (2016-2027)
10.3 Latin America Active Pharmaceutical Ingredients (API) Sales by Country
10.3.1 Latin America Active Pharmaceutical Ingredients (API) Sales by Country (2016-2027)
10.3.2 Latin America Active Pharmaceutical Ingredients (API) Revenue by Country (2016-2027)
10.3.3 Mexico
10.3.4 Brazil
10.3.5 Argentina
11 Middle East and Africa
11.1 Middle East and Africa Active Pharmaceutical Ingredients (API) Market Size by Type
11.1.1 Middle East and Africa Active Pharmaceutical Ingredients (API) Sales by Type (2016-2027)
11.1.2 Middle East and Africa Active Pharmaceutical Ingredients (API) Revenue by Type (2016-2027)
11.2 Middle East and Africa Active Pharmaceutical Ingredients (API) Market Size by Application
11.2.1 Middle East and Africa Active Pharmaceutical Ingredients (API) Sales by Application (2016-2027)
11.2.2 Middle East and Africa Active Pharmaceutical Ingredients (API) Revenue by Application (2016-2027)
11.3 Middle East and Africa Active Pharmaceutical Ingredients (API) Sales by Country
11.3.1 Middle East and Africa Active Pharmaceutical Ingredients (API) Sales by Country (2016-2027)
11.3.2 Middle East and Africa Active Pharmaceutical Ingredients (API) Revenue by Country (2016-2027)
11.3.3 Turkey
11.3.4 Saudi Arabia
11.3.5 U.A.E
12 Corporate Profiles
12.1 Teva
12.1.1 Teva Corporation Information
12.1.2 Teva Overview
12.1.3 Teva Active Pharmaceutical Ingredients (API) Sales, Price, Revenue and Gross Margin (2016-2021)
12.1.4 Teva Active Pharmaceutical Ingredients (API) Product Description
12.1.5 Teva Related Developments
12.2 Mylan
12.2.1 Mylan Corporation Information
12.2.2 Mylan Overview
12.2.3 Mylan Active Pharmaceutical Ingredients (API) Sales, Price, Revenue and Gross Margin (2016-2021)
12.2.4 Mylan Active Pharmaceutical Ingredients (API) Product Description
12.2.5 Mylan Related Developments
12.3 DSM
12.3.1 DSM Corporation Information
12.3.2 DSM Overview
12.3.3 DSM Active Pharmaceutical Ingredients (API) Sales, Price, Revenue and Gross Margin (2016-2021)
12.3.4 DSM Active Pharmaceutical Ingredients (API) Product Description
12.3.5 DSM Related Developments
12.4 Aurobindo Pharma
12.4.1 Aurobindo Pharma Corporation Information
12.4.2 Aurobindo Pharma Overview
12.4.3 Aurobindo Pharma Active Pharmaceutical Ingredients (API) Sales, Price, Revenue and Gross Margin (2016-2021)
12.4.4 Aurobindo Pharma Active Pharmaceutical Ingredients (API) Product Description
12.4.5 Aurobindo Pharma Related Developments
12.5 Aspen
12.5.1 Aspen Corporation Information
12.5.2 Aspen Overview
12.5.3 Aspen Active Pharmaceutical Ingredients (API) Sales, Price, Revenue and Gross Margin (2016-2021)
12.5.4 Aspen Active Pharmaceutical Ingredients (API) Product Description
12.5.5 Aspen Related Developments
12.6 Novartis
12.6.1 Novartis Corporation Information
12.6.2 Novartis Overview
12.6.3 Novartis Active Pharmaceutical Ingredients (API) Sales, Price, Revenue and Gross Margin (2016-2021)
12.6.4 Novartis Active Pharmaceutical Ingredients (API) Product Description
12.6.5 Novartis Related Developments
12.7 BASF
12.7.1 BASF Corporation Information
12.7.2 BASF Overview
12.7.3 BASF Active Pharmaceutical Ingredients (API) Sales, Price, Revenue and Gross Margin (2016-2021)
12.7.4 BASF Active Pharmaceutical Ingredients (API) Product Description
12.7.5 BASF Related Developments
12.8 Pfizer
12.8.1 Pfizer Corporation Information
12.8.2 Pfizer Overview
12.8.3 Pfizer Active Pharmaceutical Ingredients (API) Sales, Price, Revenue and Gross Margin (2016-2021)
12.8.4 Pfizer Active Pharmaceutical Ingredients (API) Product Description
12.8.5 Pfizer Related Developments
12.9 Huahai Pharmaceutical
12.9.1 Huahai Pharmaceutical Corporation Information
12.9.2 Huahai Pharmaceutical Overview
12.9.3 Huahai Pharmaceutical Active Pharmaceutical Ingredients (API) Sales, Price, Revenue and Gross Margin (2016-2021)
12.9.4 Huahai Pharmaceutical Active Pharmaceutical Ingredients (API) Product Description
12.9.5 Huahai Pharmaceutical Related Developments
12.10 Hisun Pharmaceutical
12.10.1 Hisun Pharmaceutical Corporation Information
12.10.2 Hisun Pharmaceutical Overview
12.10.3 Hisun Pharmaceutical Active Pharmaceutical Ingredients (API) Sales, Price, Revenue and Gross Margin (2016-2021)
12.10.4 Hisun Pharmaceutical Active Pharmaceutical Ingredients (API) Product Description
12.10.5 Hisun Pharmaceutical Related Developments
12.11 Sun Pharmaceutical Industries
12.11.1 Sun Pharmaceutical Industries Corporation Information
12.11.2 Sun Pharmaceutical Industries Overview
12.11.3 Sun Pharmaceutical Industries Active Pharmaceutical Ingredients (API) Sales, Price, Revenue and Gross Margin (2016-2021)
12.11.4 Sun Pharmaceutical Industries Active Pharmaceutical Ingredients (API) Product Description
12.11.5 Sun Pharmaceutical Industries Related Developments
12.12 Zhejiang Medicine
12.12.1 Zhejiang Medicine Corporation Information
12.12.2 Zhejiang Medicine Overview
12.12.3 Zhejiang Medicine Active Pharmaceutical Ingredients (API) Sales, Price, Revenue and Gross Margin (2016-2021)
12.12.4 Zhejiang Medicine Active Pharmaceutical Ingredients (API) Product Description
12.12.5 Zhejiang Medicine Related Developments
12.13 Dr. Reddy's Laboratories
12.13.1 Dr. Reddy's Laboratories Corporation Information
12.13.2 Dr. Reddy's Laboratories Overview
12.13.3 Dr. Reddy's Laboratories Active Pharmaceutical Ingredients (API) Sales, Price, Revenue and Gross Margin (2016-2021)
12.13.4 Dr. Reddy's Laboratories Active Pharmaceutical Ingredients (API) Product Description
12.13.5 Dr. Reddy's Laboratories Related Developments
12.14 Zhejiang NHU
12.14.1 Zhejiang NHU Corporation Information
12.14.2 Zhejiang NHU Overview
12.14.3 Zhejiang NHU Active Pharmaceutical Ingredients (API) Sales, Price, Revenue and Gross Margin (2016-2021)
12.14.4 Zhejiang NHU Active Pharmaceutical Ingredients (API) Product Description
12.14.5 Zhejiang NHU Related Developments
12.15 Bayer
12.15.1 Bayer Corporation Information
12.15.2 Bayer Overview
12.15.3 Bayer Active Pharmaceutical Ingredients (API) Sales, Price, Revenue and Gross Margin (2016-2021)
12.15.4 Bayer Active Pharmaceutical Ingredients (API) Product Description
12.15.5 Bayer Related Developments
12.16 NCPC
12.16.1 NCPC Corporation Information
12.16.2 NCPC Overview
12.16.3 NCPC Active Pharmaceutical Ingredients (API) Sales, Price, Revenue and Gross Margin (2016-2021)
12.16.4 NCPC Active Pharmaceutical Ingredients (API) Product Description
12.16.5 NCPC Related Developments
12.17 AbbVie
12.17.1 AbbVie Corporation Information
12.17.2 AbbVie Overview
12.17.3 AbbVie Active Pharmaceutical Ingredients (API) Sales, Price, Revenue and Gross Margin (2016-2021)
12.17.4 AbbVie Active Pharmaceutical Ingredients (API) Product Description
12.17.5 AbbVie Related Developments
12.18 Shandong Xinhua Pharmaceutical
12.18.1 Shandong Xinhua Pharmaceutical Corporation Information
12.18.2 Shandong Xinhua Pharmaceutical Overview
12.18.3 Shandong Xinhua Pharmaceutical Active Pharmaceutical Ingredients (API) Sales, Price, Revenue and Gross Margin (2016-2021)
12.18.4 Shandong Xinhua Pharmaceutical Active Pharmaceutical Ingredients (API) Product Description
12.18.5 Shandong Xinhua Pharmaceutical Related Developments
12.19 Northeast Pharm
12.19.1 Northeast Pharm Corporation Information
12.19.2 Northeast Pharm Overview
12.19.3 Northeast Pharm Active Pharmaceutical Ingredients (API) Sales, Price, Revenue and Gross Margin (2016-2021)
12.19.4 Northeast Pharm Active Pharmaceutical Ingredients (API) Product Description
12.19.5 Northeast Pharm Related Developments
12.20 Harbin Pharmaceutical
12.20.1 Harbin Pharmaceutical Corporation Information
12.20.2 Harbin Pharmaceutical Overview
12.20.3 Harbin Pharmaceutical Active Pharmaceutical Ingredients (API) Sales, Price, Revenue and Gross Margin (2016-2021)
12.20.4 Harbin Pharmaceutical Active Pharmaceutical Ingredients (API) Product Description
12.20.5 Harbin Pharmaceutical Related Developments
8.21 LKPC
12.21.1 LKPC Corporation Information
12.21.2 LKPC Overview
12.21.3 LKPC Active Pharmaceutical Ingredients (API) Sales, Price, Revenue and Gross Margin (2016-2021)
12.21.4 LKPC Active Pharmaceutical Ingredients (API) Product Description
12.21.5 LKPC Related Developments
13 Industry Chain and Sales Channels Analysis
13.1 Active Pharmaceutical Ingredients (API) Industry Chain Analysis
13.2 Active Pharmaceutical Ingredients (API) Key Raw Materials
13.2.1 Key Raw Materials
13.2.2 Raw Materials Key Suppliers
13.3 Active Pharmaceutical Ingredients (API) Production Mode & Process
13.4 Active Pharmaceutical Ingredients (API) Sales and Marketing
13.4.1 Active Pharmaceutical Ingredients (API) Sales Channels
13.4.2 Active Pharmaceutical Ingredients (API) Distributors
13.5 Active Pharmaceutical Ingredients (API) Customers
14 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
14.1 Active Pharmaceutical Ingredients (API) Industry Trends
14.2 Active Pharmaceutical Ingredients (API) Market Drivers
14.3 Active Pharmaceutical Ingredients (API) Market Challenges
14.4 Active Pharmaceutical Ingredients (API) Market Restraints
15 Key Finding in The Global Active Pharmaceutical Ingredients (API) Study
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
List of TablesTable 1. Global Active Pharmaceutical Ingredients (API) Market Size Growth Rate by Type, 2016 VS 2021 VS 2027 (US$ Million)
Table 2. Major Manufacturers of Synthetic APIs
Table 3. Major Manufacturers of Biotech APIs
Table 4. Global Active Pharmaceutical Ingredients (API) Market Size Growth Rate by Application, 2016 VS 2021 2027 (US$ Million)
Table 5. Global Active Pharmaceutical Ingredients (API) Production by Region: 2016 VS 2021 VS 2027 (K MT)
Table 6. Global Active Pharmaceutical Ingredients (API) Production by Region (2016-2021) & (K MT)
Table 7. Global Active Pharmaceutical Ingredients (API) Production Market Share by Region (2016-2021)
Table 8. Global Active Pharmaceutical Ingredients (API) Production by Region (2022-2027) & (K MT)
Table 9. Global Active Pharmaceutical Ingredients (API) Production Market Share by Region (2022-2027)
Table 10. Global Active Pharmaceutical Ingredients (API) Revenue by Region: 2016 VS 2021 VS 2027 (US$ Million)
Table 11. Global Active Pharmaceutical Ingredients (API) Sales by Region (2016-2021) & (K MT)
Table 12. Global Active Pharmaceutical Ingredients (API) Sales Market Share by Region (2016-2021)
Table 13. Global Active Pharmaceutical Ingredients (API) Sales by Region (2022-2027) & (K MT)
Table 14. Global Active Pharmaceutical Ingredients (API) Sales Market Share by Region (2022-2027)
Table 15. Global Active Pharmaceutical Ingredients (API) Revenue by Region (2016-2021) & (US$ Million)
Table 16. Global Active Pharmaceutical Ingredients (API) Revenue Market Share by Region (2016-2021)
Table 17. Global Active Pharmaceutical Ingredients (API) Revenue by Region (2022-2027) & (US$ Million)
Table 18. Global Active Pharmaceutical Ingredients (API) Revenue Market Share by Region (2022-2027)
Table 19. Global Active Pharmaceutical Ingredients (API) Production Capacity by Manufacturers (2016-2021) & (K MT)
Table 20. Global Active Pharmaceutical Ingredients (API) Capacity Market Share by Manufacturers (2016-2021)
Table 21. Global Active Pharmaceutical Ingredients (API) Production by Manufacturers (2016-2021) & (K MT)
Table 22. Global Active Pharmaceutical Ingredients (API) Production Market Share by Manufacturers (2016-2021)
Table 23. Global Active Pharmaceutical Ingredients (API) Sales by Manufacturers (2016-2021) & (K MT)
Table 24. Global Active Pharmaceutical Ingredients (API) Sales Share by Manufacturers (2016-2021)
Table 25. Global Active Pharmaceutical Ingredients (API) Revenue by Manufacturers (2016-2021) & (US$ Million)
Table 26. Global Active Pharmaceutical Ingredients (API) Revenue Share by Manufacturers (2016-2021)
Table 27. Active Pharmaceutical Ingredients (API) Price by Manufacturers 2016-2021 (USD/MT)
Table 28. Global Active Pharmaceutical Ingredients (API) Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 29. Global Active Pharmaceutical Ingredients (API) by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Active Pharmaceutical Ingredients (API) as of 2020)
Table 30. Active Pharmaceutical Ingredients (API) Manufacturing Base Distribution and Headquarters
Table 31. Manufacturers Active Pharmaceutical Ingredients (API) Product Offered
Table 32. Date of Manufacturers Enter into Active Pharmaceutical Ingredients (API) Market
Table 33. Mergers & Acquisitions, Expansion Plans
Table 34. Global Active Pharmaceutical Ingredients (API) Sales by Type (2016-2021) & (K MT)
Table 35. Global Active Pharmaceutical Ingredients (API) Sales by Type (2022-2027) & (K MT)
Table 36. Global Active Pharmaceutical Ingredients (API) Sales Share by Type (2016-2021)
Table 37. Global Active Pharmaceutical Ingredients (API) Sales Share by Type (2022-2027)
Table 38. Global Active Pharmaceutical Ingredients (API) Revenue by Type (2016-2021) & (US$ Million)
Table 39. Global Active Pharmaceutical Ingredients (API) Revenue by Type (2022-2027) & (US$ Million)
Table 40. Global Active Pharmaceutical Ingredients (API) Revenue Share by Type (2016-2021)
Table 41. Global Active Pharmaceutical Ingredients (API) Revenue Share by Type (2022-2027)
Table 42. Active Pharmaceutical Ingredients (API) Price by Type (2016-2021) & (USD/MT)
Table 43. Global Active Pharmaceutical Ingredients (API) Price Forecast by Type (2022-2027) & (USD/MT)
Table 44. Global Active Pharmaceutical Ingredients (API) Sales by Application (2016-2021) & (K MT)
Table 45. Global Active Pharmaceutical Ingredients (API) Sales by Application (2022-2027) & (K MT)
Table 46. Global Active Pharmaceutical Ingredients (API) Sales Share by Application (2016-2021)
Table 47. Global Active Pharmaceutical Ingredients (API) Sales Share by Application (2022-2027)
Table 48. Global Active Pharmaceutical Ingredients (API) Revenue by Application (2016-2021) & (US$ Million)
Table 49. Global Active Pharmaceutical Ingredients (API) Revenue by Application (2022-2027) & (US$ Million)
Table 50. Global Active Pharmaceutical Ingredients (API) Revenue Share by Application (2016-2021)
Table 51. Global Active Pharmaceutical Ingredients (API) Revenue Share by Application (2022-2027)
Table 52. Active Pharmaceutical Ingredients (API) Price by Application (2016-2021) & (USD/MT)
Table 53. Global Active Pharmaceutical Ingredients (API) Price Forecast by Application (2022-2027) & (USD/MT)
Table 54. North America Active Pharmaceutical Ingredients (API) Sales by Type (2016-2021) & (K MT)
Table 55. North America Active Pharmaceutical Ingredients (API) Sales by Type (2022-2027) & (K MT)
Table 56. North America Active Pharmaceutical Ingredients (API) Revenue by Type (2016-2021) & (US$ Million)
Table 57. North America Active Pharmaceutical Ingredients (API) Revenue by Type (2022-2027) & (US$ Million)
Table 58. North America Active Pharmaceutical Ingredients (API) Sales by Application (2016-2021) & (K MT)
Table 59. North America Active Pharmaceutical Ingredients (API) Sales by Application (2022-2027) & (K MT)
Table 60. North America Active Pharmaceutical Ingredients (API) Revenue by Application (2016-2021) & (US$ Million)
Table 61. North America Active Pharmaceutical Ingredients (API) Revenue by Application (2022-2027) & (US$ Million)
Table 62. North America Active Pharmaceutical Ingredients (API) Sales by Country (2016-2021) & (K MT)
Table 63. North America Active Pharmaceutical Ingredients (API) Sales by Country (2022-2027) & (K MT)
Table 64. North America Active Pharmaceutical Ingredients (API) Revenue by Country (2016-2021) & (US$ Million)
Table 65. North America Active Pharmaceutical Ingredients (API) Revenue by Country (2022-2027) & (US$ Million)
Table 66. Europe Active Pharmaceutical Ingredients (API) Sales by Type (2016-2021) & (K MT)
Table 67. Europe Active Pharmaceutical Ingredients (API) Sales by Type (2022-2027) & (K MT)
Table 68. Europe Active Pharmaceutical Ingredients (API) Revenue by Type (2016-2021) & (US$ Million)
Table 69. Europe Active Pharmaceutical Ingredients (API) Revenue by Type (2022-2027) & (US$ Million)
Table 70. Europe Active Pharmaceutical Ingredients (API) Sales by Application (2016-2021) & (K MT)
Table 71. Europe Active Pharmaceutical Ingredients (API) Sales by Application (2022-2027) & (K MT)
Table 72. Europe Active Pharmaceutical Ingredients (API) Revenue by Application (2016-2021) & (US$ Million)
Table 73. Europe Active Pharmaceutical Ingredients (API) Revenue by Application (2022-2027) & (US$ Million)
Table 74. Europe Active Pharmaceutical Ingredients (API) Sales by Country (2016-2021) & (K MT)
Table 75. Europe Active Pharmaceutical Ingredients (API) Sales by Country (2022-2027) & (K MT)
Table 76. Europe Active Pharmaceutical Ingredients (API) Revenue by Country (2016-2021) & (US$ Million)
Table 77. Europe Active Pharmaceutical Ingredients (API) Revenue by Country (2022-2027) & (US$ Million)
Table 78. Asia Pacific Active Pharmaceutical Ingredients (API) Sales by Type (2016-2021) & (K MT)
Table 79. Asia Pacific Active Pharmaceutical Ingredients (API) Sales by Type (2022-2027) & (K MT)
Table 80. Asia Pacific Active Pharmaceutical Ingredients (API) Revenue by Type (2016-2021) & (US$ Million)
Table 81. Asia Pacific Active Pharmaceutical Ingredients (API) Revenue by Type (2022-2027) & (US$ Million)
Table 82. Asia Pacific Active Pharmaceutical Ingredients (API) Sales by Application (2016-2021) & (K MT)
Table 83. Asia Pacific Active Pharmaceutical Ingredients (API) Sales by Application (2022-2027) & (K MT)
Table 84. Asia Pacific Active Pharmaceutical Ingredients (API) Revenue by Application (2016-2021) & (US$ Million)
Table 85. Asia Pacific Active Pharmaceutical Ingredients (API) Revenue by Application (2022-2027) & (US$ Million)
Table 86. Asia Pacific Active Pharmaceutical Ingredients (API) Sales by Region (2016-2021) & (K MT)
Table 87. Asia Pacific Active Pharmaceutical Ingredients (API) Sales by Region (2022-2027) & (K MT)
Table 88. Asia Pacific Active Pharmaceutical Ingredients (API) Revenue by Region (2016-2021) & (US$ Million)
Table 89. Asia Pacific Active Pharmaceutical Ingredients (API) Revenue by Region (2022-2027) & (US$ Million)
Table 90. Latin America Active Pharmaceutical Ingredients (API) Sales by Type (2016-2021) & (K MT)
Table 91. Latin America Active Pharmaceutical Ingredients (API) Sales by Type (2022-2027) & (K MT)
Table 92. Latin America Active Pharmaceutical Ingredients (API) Revenue by Type (2016-2021) & (US$ Million)
Table 93. Latin America Active Pharmaceutical Ingredients (API) Revenue by Type (2022-2027) & (US$ Million)
Table 94. Latin America Active Pharmaceutical Ingredients (API) Sales by Application (2016-2021) & (K MT)
Table 95. Latin America Active Pharmaceutical Ingredients (API) Sales by Application (2022-2027) & (K MT)
Table 96. Latin America Active Pharmaceutical Ingredients (API) Revenue by Application (2016-2021) & (US$ Million)
Table 97. Latin America Active Pharmaceutical Ingredients (API) Revenue by Application (2022-2027) & (US$ Million)
Table 98. Latin America Active Pharmaceutical Ingredients (API) Sales by Country (2016-2021) & (K MT)
Table 99. Latin America Active Pharmaceutical Ingredients (API) Sales by Country (2022-2027) & (K MT)
Table 100. Latin America Active Pharmaceutical Ingredients (API) Revenue by Country (2016-2021) & (US$ Million)
Table 101. Latin America Active Pharmaceutical Ingredients (API) Revenue by Country (2022-2027) & (US$ Million)
Table 102. Middle East and Africa Active Pharmaceutical Ingredients (API) Sales by Type (2016-2021) & (K MT)
Table 103. Middle East and Africa Active Pharmaceutical Ingredients (API) Sales by Type (2022-2027) & (K MT)
Table 104. Middle East and Africa Active Pharmaceutical Ingredients (API) Revenue by Type (2016-2021) & (US$ Million)
Table 105. Middle East and Africa Active Pharmaceutical Ingredients (API) Revenue by Type (2022-2027) & (US$ Million)
Table 106. Middle East and Africa Active Pharmaceutical Ingredients (API) Sales by Application (2016-2021) & (K MT)
Table 107. Middle East and Africa Active Pharmaceutical Ingredients (API) Sales by Application (2022-2027) & (K MT)
Table 108. Middle East and Africa Active Pharmaceutical Ingredients (API) Revenue by Application (2016-2021) & (US$ Million)
Table 109. Middle East and Africa Active Pharmaceutical Ingredients (API) Revenue by Application (2022-2027) & (US$ Million)
Table 110. Middle East and Africa Active Pharmaceutical Ingredients (API) Sales by Country (2016-2021) & (K MT)
Table 111. Middle East and Africa Active Pharmaceutical Ingredients (API) Sales by Country (2022-2027) & (K MT)
Table 112. Middle East and Africa Active Pharmaceutical Ingredients (API) Revenue by Country (2016-2021) & (US$ Million)
Table 113. Middle East and Africa Active Pharmaceutical Ingredients (API) Revenue by Country (2022-2027) & (US$ Million)
Table 114. Teva Corporation Information
Table 115. Teva Description and Major Businesses
Table 116. Teva Active Pharmaceutical Ingredients (API) Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2016-2021)
Table 117. Teva Active Pharmaceutical Ingredients (API) Product
Table 118. Teva Recent Development
Table 119